All PlansCoverageHigh impact
Evaluating the Utility of Genetic Panels
Regence BlueShield·Oncology, Hematology, Neurology +7 more·Coding
Effective date
Apr 1, 2026
We identified it
Jun 16, 2026
Summary
This new policy declares numerous genetic panel tests as investigational and not covered when genes in the panel lack demonstrated clinical utility for treatment decisions. The policy lists over 100 specific genetic panel tests from various laboratories that are considered investigational.
Action Required
Before April 1, 2026: Billing team must update prior authorization systems to flag genetic panel tests as investigational/non-covered. Review the extensive list of affected panels and cross-reference with current orders. Update encounter forms to alert providers that these panels may not be covered and patients should be informed of financial responsibility. Establish workflow to verify coverage before ordering genetic panels not on the investigational list.